Skip to Content

22 Results Found

  • Review
  • Open Access
41 Citations
8,321 Views
33 Pages

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists

  • Berthold A. Nock,
  • Panagiotis Kanellopoulos,
  • Lieke Joosten,
  • Rosalba Mansi and
  • Theodosia Maina

30 April 2023

The clinical success of radiolabeled somatostatin analogs in the diagnosis and therapy—“theranostics”—of tumors expressing the somatostatin subtype 2 receptor (SST2R) has paved the way for the development of a broader panel of...

(This article belongs to the Special Issue Feature Reviews in Radiopharmaceutical Sciences: Highlights of Two-Decade Development)
  • Article
  • Open Access
10 Citations
5,677 Views
14 Pages

Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses

  • Aikaterini Kaloudi,
  • Emmanouil Lymperis,
  • Panagiotis Kanellopoulos,
  • Beatrice Waser and ,
  • Marion de Jong,
  • Eric P. Krenning,
  • Jean Claude Reubi,
  • Berthold A. Nock and
  • Theodosia Maina
  • + 4 authors+ 0 author

The overexpression of gastrin-releasing peptide receptors (GRPRs) in frequently occurring human tumors has provided the opportunity to use bombesin (BBN) analogs as radionuclide carriers to cancer sites for diagnostic and therapeutic purposes. We hav...

(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)
  • Article
  • Open Access
4 Citations
2,915 Views
19 Pages

Novel 177Lu-Labeled [Thz14]Bombesin(6–14) Derivatives with Low Pancreas Accumulation for Targeting Gastrin-Releasing Peptide Receptor-Expressing Cancer

  • Lei Wang,
  • Devon E. Chapple,
  • Hsiou-Ting Kuo,
  • Sara Kurkowska and ,
  • Ryan P. Wilson,
  • Wing Sum Lau,
  • Pauline Ng,
  • Carlos Uribe,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 5 authors+ 0 author

23 March 2025

Background/Objectives: Gastrin-releasing peptide receptor is a promising target for cancer diagnosis and therapy. However, the high pancreas uptake of reported GRPR-targeted radioligands limits their clinical applications. Our group previously report...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Article
  • Open Access
16 Citations
3,241 Views
14 Pages

One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto

  • Panagiotis Kanellopoulos,
  • Aikaterini Kaloudi,
  • Maritina Rouchota,
  • George Loudos and ,
  • Marion de Jong,
  • Eric P. Krenning,
  • Berthold A. Nock and
  • Theodosia Maina
  • + 3 authors+ 0 author

Background: Peptide radioligands may serve as radionuclide carriers to tumor sites overexpressing their cognate receptor for diagnostic or therapeutic purposes. Treatment of mice with the neprilysin (NEP)-inhibitor phosphoramidon was previously shown...

(This article belongs to the Special Issue Targeted Radionuclide Therapy)
  • Article
  • Open Access
12 Citations
3,987 Views
19 Pages

Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK2R Cancer Theranostic Agents: A Preclinical Study

  • Berthold A. Nock,
  • Panagiotis Kanellopoulos,
  • Oleg G. Chepurny,
  • Maritina Rouchota and ,
  • George Loudos,
  • George G. Holz,
  • Eric P. Krenning and
  • Theodosia Maina
  • + 3 authors+ 0 author

(1) Background: Theranostic approaches in the management of cholecystokinin subtype 2 receptor (CCK2R)-positive tumors include radiolabeled gastrin and CCK motifs. Moving toward antagonist-based CCK2R-radioligands instead, we herein present three ana...

(This article belongs to the Special Issue Recent Advances in Radiopharmaceutics)
  • Article
  • Open Access
14 Citations
5,122 Views
15 Pages

Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation

  • Fanny Lundmark,
  • Ayman Abouzayed,
  • Sara S. Rinne,
  • Vasiliy Timofeev and ,
  • Nadezhda Sipkina,
  • Maria Naan,
  • Anastasia Kirichenko,
  • Maria Vasyutina,
  • Daria Ryzhkova and
  • Anna Orlova
  • + 7 authors+ 2 authors

10 January 2023

The development of radioligands targeting prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR) has shown promising results for the imaging and therapy of prostate cancer. However, studies have shown that tumors and...

(This article belongs to the Special Issue Diagnostic and Treatment for Three Urological Cancers: Bladder Cancer, Kidney Cancer and Prostate Cancer)
  • Article
  • Open Access
12 Citations
3,885 Views
15 Pages

68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake

  • Lei Wang,
  • Ivica Jerolim Bratanovic,
  • Zhengxing Zhang,
  • Hsiou-Ting Kuo and ,
  • Helen Merkens,
  • Jutta Zeisler,
  • Chengcheng Zhang,
  • Ruiyan Tan,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 5 authors+ 0 author

20 February 2023

With overexpression in various cancers, the gastrin-releasing peptide receptor (GRPR) is a promising target for cancer imaging and therapy. However, the high pancreas uptake of reported GRPR-targeting radioligands limits their clinical application. O...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
52 Citations
13,759 Views
22 Pages

Abstract: Nuclear medicine plays a pivotal role in the management of patients affected by neuroendocrine neoplasms (NENs). Radiolabeled somatostatin receptor analogs are by far the most advanced radiopharmaceuticals for diagnosis and therapy (radioth...

(This article belongs to the Special Issue Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development)
  • Article
  • Open Access
24 Citations
3,761 Views
14 Pages

68Ga-Labeled [Leu13ψThz14]Bombesin(7–14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake

  • Lei Wang,
  • Zhengxing Zhang,
  • Helen Merkens,
  • Jutta Zeisler and ,
  • Chengcheng Zhang,
  • Aron Roxin,
  • Ruiyan Tan,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 4 authors+ 0 author

11 June 2022

The gastrin-releasing peptide receptor (GRPR) is a G-protein-coupled receptor that is overexpressed in many solid cancers and is a promising target for cancer imaging and therapy. However, high pancreas uptake is a major concern in the application of...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
17 Citations
9,029 Views
26 Pages

Targeted radioligand therapy (RLT) is an emerging field in anticancer therapeutics with great potential across tumor types and stages of disease. While much progress has focused on agents targeting somatostatin receptors and prostate-specific membran...

(This article belongs to the Section Cancer Imaging)
  • Article
  • Open Access
17 Citations
6,329 Views
20 Pages

Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors—An Improvement for Breast Cancer Imaging?

  • Alicia Vall-Sagarra,
  • Shanna Litau,
  • Clemens Decristoforo,
  • Björn Wängler and ,
  • Ralf Schirrmacher,
  • Gert Fricker and
  • Carmen Wängler
  • + 2 authors+ 0 author

Heterobivalent peptidic ligands (HBPLs), designed to address two different receptors independently, are highly promising tumor imaging agents. For example, breast cancer has been shown to concomitantly and complementarily overexpress the neuropeptide...

(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)
  • Review
  • Open Access
9 Citations
3,957 Views
12 Pages

Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review

  • Mathieu Gauthé,
  • Paul Sargos,
  • Eric Barret,
  • Gaëlle Fromont-Hankard and ,
  • Jean-Baptiste Beauval,
  • Laurent Brureau,
  • Gilles Créhange,
  • Raphaële Renard-Penna,
  • Charles Dariane and
  • on behalf of the CC-AFU
  • + 11 authors+ 6 authors

24 October 2021

Background: Prostate-specific membrane antigen (PSMA) is not sufficiently overexpressed in a small proportion of prostate cancer (PCa) patients, who require other strategies for imaging and/or treatment. We reviewed potential targets other than PSMA...

(This article belongs to the Section Oncology)
  • Review
  • Open Access
20 Citations
5,892 Views
26 Pages

Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer

  • Luca Filippi,
  • Viviana Frantellizzi,
  • Agostino Chiaravalloti,
  • Mariano Pontico and ,
  • Maria Silvia De Feo,
  • Ferdinando Corica,
  • Melissa Montebello,
  • Orazio Schillaci,
  • Giuseppe De Vincentis and
  • Oreste Bagni
  • + 5 authors+ 0 author

Metastatic castration-resistant prostate cancer (mCRPC) represents a condition of progressive disease in spite of androgen deprivation therapy (ADT), with a broad spectrum of manifestations ranging from no symptoms to severe debilitation due to bone...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
11 Citations
4,528 Views
13 Pages

Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [68Ga]Ga-RM2—A Head-to-Head Pilot Comparison with [68Ga]Ga-PSMA-11

  • René Fernández,
  • Cristian Soza-Ried,
  • Andrei Iagaru,
  • Andrew Stephens and ,
  • Andre Müller,
  • Hanno Schieferstein,
  • Camilo Sandoval,
  • Horacio Amaral and
  • Vasko Kramer
  • + 4 authors+ 0 author

29 December 2023

Background: The gastrin-releasing peptide receptor (GRPr) is highly overexpressed in several solid tumors, including treatment-naïve and recurrent prostate cancer. [68Ga]Ga-RM2 is a well-established radiotracer for PET imaging of GRPr, and [177L...

(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment - 2nd Volume)
  • Article
  • Open Access
3 Citations
3,903 Views
22 Pages

Synthesis and Evaluation of 68Ga- and 177Lu-Labeled [diF-Pro14]Bombesin(6−14) Analogs for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer

  • Lei Wang,
  • Chao-Cheng Chen,
  • Devon Chapple,
  • Antonio A. W. L. Wong and ,
  • Sara Kurkowska,
  • Wing Sum Lau,
  • Carlos F. Uribe,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 4 authors+ 0 author

8 February 2025

Background/Objectives: Overexpressed in various solid tumors, the gastrin-releasing peptide receptor (GRPR) is a promising target for cancer diagnosis and therapy. However, the high pancreas uptake of the current clinically evaluated GRPR-targeted ra...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Article
  • Open Access
10 Citations
5,082 Views
16 Pages

GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics

  • Karim Obeid,
  • Panagiotis Kanellopoulos,
  • Ayman Abouzayed,
  • Adam Mattsson and ,
  • Vladimir Tolmachev,
  • Berthold A. Nock,
  • Theodosia Maina and
  • Anna Orlova
  • + 3 authors+ 0 author

Gastrin-releasing peptide receptor (GRPR)-antagonists have served as motifs in the development of theranostic radioligands for prostate cancer. Our efforts have been focused on the development of radiolabeled RM26 (H-DPhe6–Gln7–Trp8&ndash...

(This article belongs to the Special Issue Advances in Radiopharmaceuticals for Disease Diagnoses and Therapy)
  • Article
  • Open Access
21 Citations
4,137 Views
8 Pages

Gastrin-Releasing Peptide Receptor Antagonist [68Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer

  • Kerstin Michalski,
  • Lars Kemna,
  • Jasmin Asberger,
  • Anca L. Grosu and ,
  • Philipp T. Meyer,
  • Juri Ruf and
  • Tanja Sprave
  • + 2 authors+ 0 author

3 December 2021

Background: Positron emission tomography (PET)/computed tomography (CT) using the gastrin-releasing peptide receptor antagonist [68Ga]RM2 has shown to be a promising imaging method for primary breast cancer (BC) with positive estrogen receptor (ER) s...

(This article belongs to the Special Issue Breast Cancer Imaging: Current Trends and Future Direction)
  • Article
  • Open Access
5 Citations
2,802 Views
12 Pages

Synthesis and Evaluation of the First 68Ga-Labeled C-Terminal Hydroxamate-Derived Gastrin-Releasing Peptide Receptor-Targeted Tracers for Cancer Imaging with Positron Emission Tomography

  • Lei Wang,
  • Hsiou-Ting Kuo,
  • Chao-Cheng Chen,
  • Devon Chapple and ,
  • Nadine Colpo,
  • Pauline Ng,
  • Wing Sum Lau,
  • Shireen Jozi,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 5 authors+ 0 author

28 June 2024

Gastrin-releasing peptide receptor (GRPR), overexpressed in many solid tumors, is a promising imaging marker and therapeutic target. Most reported GRPR-targeted radioligands contain a C-terminal amide. Based on the reported potent antagonist D-Phe-Gl...

(This article belongs to the Special Issue New Advances in Radiopharmaceutical Sciences)
  • Article
  • Open Access
6 Citations
2,972 Views
15 Pages

Synthesis and Evaluation of Novel 68Ga-Labeled [D-Phe6,Leu13ψThz14]bombesin(6-14) Analogs for Cancer Imaging with Positron Emission Tomography

  • Lei Wang,
  • Chao-Cheng Chen,
  • Zhengxing Zhang,
  • Hsiou-Ting Kuo and ,
  • Chengcheng Zhang,
  • Nadine Colpo,
  • Helen Merkens,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 4 authors+ 0 author

Gastrin-releasing peptide receptor (GRPR) is overexpressed in various cancers and is a promising target for cancer diagnosis and therapy. However, the high pancreas uptake and/or metabolic instability observed for most reported GRPR-targeted radiolig...

(This article belongs to the Special Issue Development of Radiolabeled Peptides)
  • Article
  • Open Access
12 Citations
3,404 Views
13 Pages

[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models

  • Panagiotis Kanellopoulos,
  • Emmanouil Lymperis,
  • Aikaterini Kaloudi,
  • Marion de Jong and ,
  • Eric P. Krenning,
  • Berthold A. Nock and
  • Theodosia Maina
  • + 2 authors+ 0 author

28 July 2020

Background: The frequent overexpression of gastrin-releasing peptide receptors (GRPRs) in human cancers provides the rationale for delivering clinically useful radionuclides to tumor sites using peptide carriers. Radiolabeled GRPR antagonists, beside...

(This article belongs to the Special Issue Past, Present, and Future of Radiochemical Synthesis)
  • Article
  • Open Access
461 Views
23 Pages

Development of a GRPR-Targeted 99mTc/188Re Theranostic Pair Based on NOTA-P2-RM26

  • Antonio Shegani,
  • Nektarios Pirmettis,
  • Sotiria Triantopoulou,
  • Areti Titoni and ,
  • Adrianna Travlou,
  • Georgia I. Terzoudi,
  • Minas Papadopoulos,
  • Ioannis Pirmettis and
  • Charalampos Triantis
  • + 4 authors+ 0 author

Background: Gastrin-releasing peptide receptor (GRPR)-targeted radioligands are promising tools for imaging and treatment of GRPR-expressing malignancies. This study aimed to develop a NOTA-P2-RM26-based 99mTc/188Re theranostic pair using the fac-[M(...

(This article belongs to the Special Issue Theranostic Metal-Organic Radiocarriers for Targeted Delivery and In Vivo Regulation)
  • Article
  • Open Access
6 Citations
3,643 Views
20 Pages

Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study

  • Sofía González-Rueda,
  • Osvaldo García-Pérez,
  • Myrna Luna-Gutiérrez,
  • Blanca Ocampo-García and ,
  • Clara Santos-Cuevas,
  • Gerardo Ramírez-Nava,
  • Joel Vargas-Ahumada,
  • Erika Azorín-Vega,
  • Guillermina Ferro-Flores and
  • Laura Meléndez-Alafort
  • + 5 authors+ 0 author

Background/Objectives: Prostate cancer (PC) represents the second most diagnosed form of cancer in men on a global scale. Despite the theranostic efficacy of prostate-specific membrane antigen (PSMA) radioligands, there is a spectrum of PC disease in...

(This article belongs to the Special Issue Advances in Radiopharmaceuticals for Disease Diagnoses and Therapy)